Fischer Medical Ventures appointed Mr. David Yeow, a seasoned engineer and medical device VC principal, as an Independent Director, enhancing board expertise. This led to Audit Committee reconstitution. The company also announced its 33rd Annual General Meeting.
Fischer Medical Ventures subsidiary launches next-gen CLARION AI-driven CT system in India, enhancing medical imaging capabilities and diagnostic efficiency.
Fischer Medical Ventures' subsidiary, Time Medical Philippines, secured a province-wide digital healthcare project in Catanduanes. This involves integrating Health Kiosks with the FlynnCare Clinic Management System, aiming to enhance healthcare accessibility and digitalization.
Fischer Medical Ventures converted 4,54,210 warrants into equity shares for promoter FMV Holdings Pte Ltd, raising Rs. 79.71 Lakhs.
Fischer Medical Ventures announces board meeting to approve conversion of warrants into 2.05 crore equity shares. This raises Rs. 36 Cr cash, increasing share capital.
